SlideShare a Scribd company logo
1 of 11
POPULATION GENETICS AND ECOLOGY
PRESENTATION
GROUP FOUR
Members Index number
• COFFIE BAIDOO RABBI UE20015317
• BUABENG ISAAC KOJO UE20015117
• DARKWAH JEPHTER UE20015717
• BALASU DELIGHT UE20014417
• BOATENG DAVID UE20014817
• BABAE THEOPHILUS UE20014217
• BRUCE BELINDAASIEDUA UE20015017
• DADEBOE VANESSA OHUI UE20014217
HOW DOES HIV-1 AFFECT THE BODY?
The human immunodeficiency virus is a lentivirus that causes HIV
infection and over time acquired immunodeficiency syndrome.
HIV attacks a specific type of immune system cell in the body. It is
known as the CD4 helper cell or T cell. The CD4 cell(cluster of
differentiation 4) is a glycoprotein found on the surface of immune
cells such as T helper cells, monocytes, macrophages and dendritic
cells.
When HIV destroy this cells, it becomes harder for the body to
fight other infections. When HIV is left untreated even a minor
infection such as cold can be much more severe because the body
has difficulty responding to new infections.
HIV does not only attack CD4 cells, it also uses the cells to make
more of the virus. HIV destroy CD4 cells by using their
replication machine to create new copies of the virus and this
causes the CD4 cells to swell and burst.
When the virus has destroyed a certain number of CD4 cells, the
CD4 count drop below 200(the normal CD4 count ranges from
approximately 500 to 1,600 cells/mm3 in healthy adults) then a
person will progress to have AIDS.
CERTAIN INDIVIDUALS CARRY A MUTATION
PROTECTING THEM AGAINST HIV, DISCUSS.
Some years ago, 1% descended from Northern Europeans,
particularly Swedes, were immune to HIV infection. These lucky
people are homozygous carriers of a mutated gene meaning that
they inherited a copy from both of their parents.
Just one copy of the gene does not prevent against the infection.
Hence the mutation has not been found in Africans, East Asians,
or Amerindians (NATIVE AMERICANS).
A genetic mutation known as CCR5Δ32 is responsible for HIV
resistance that exist. CCR5Δ32 hampers HIV ability to infilterate
immune cells.
Note; CCR5 stands for C-C Chemokine receptor type 5.
The mutations causes the CCR5 co-receptor on the outside of the
cells to develop smaller than usual and no longer sit outside of
the cell.
The CCR5 co-receptor is like the door that allows HIV entrance
into the cell. The CCR5Δ32 mutation in a sense locks the door
which prevents HIV from entering into the cell.
CCR5Δ32 is exciting. It present possibilities for new ways to
protect against HIV. There are some genetic test available to
see if one has the mutation. But it is not yet widespread.
The mutation is not completely full proof.
Cases of homozygous carrier that have become infected
with HIV have been reported.
These few exceptions have dissuaded health officials
from fully supporting genetic test over ethical concerns.
It would not be wise for those with the mutation to
assume that they can lead a dangerous lifestyle and
remain healthy.
Understanding why and how certain people are resistant
to HIV with the help of CCR5Δ32 will hopefully lead to
a new and highly successful treatments in our lifetime.
Consider a sample population of 100 French individuals
in Britain. Among this group 79 individuals had
genotype +/+, 20 had +/Δ32 and 1 had a genotype of
Δ32/Δ32, what are the possible allelic frequencies?
• +/+ normal allele of the gene
• Δ32/Δ32 mutant
• +/Δ32 heterozygote
SOLUTION
Given that;
Total population = 100
Individuals with normal allele of the gene (+/+) = 79
Individuals that carries the mutant gene (Δ32/Δ32) = 1
Heterozygous individuals of the gene (+/Δ32) = 20
To solve for the allelic frequency of +/+
= (+/+) x 2 + (+/Δ32) / (total population x 2)
= (79 x 2) + 20 / (100 x 2)
= 158 + 20 / 200
= 178 / 200
= 0.89
To solve for the allelic frequency of Δ32/Δ32
= (Δ32/Δ32) x 2 + (+/Δ32) / 200
= (1 x 2) + 20 / 200
= 22 / 200
= 0.11
From Hardy-Weinberg equation;
The sum of all tree genotypes is p2 + 2pq +q2 = 1
LET;
• The probability of forming an +/+ zygote = p2
• The probability of forming an Δ32/Δ32 zygote = q2
• The probability of forming an +/Δ32 zygote = (p x q) + (q x p)
• = pq + qp
• = 2pq
Substitute the values of p and q into the equation,
= p2 + 2pq + q2
= (0.89)2 + 2(0.89 x0.11) + (0.11)2
= 0.7921 + 0.1958 + 0.0121
= 1.
(note; the probability of 1 means certainty, and every
individual must be one of the three genotypes)
References;
Dotinga , R. “Genetic HIV Resistance Deciphered” Wired. January 7, 2005
Evolution. Double Immunity (2001).
Novembre, J., Galvani, A., and Slatkin, M. The Geographic Spread of the CCR5 Δ32
HIV Resistance Allele. PLOS Biology (2004)
Biology, BURTON S. GUTTMAN

More Related Content

What's hot

Huntington's Disease
Huntington's DiseaseHuntington's Disease
Huntington's Disease
Myzak
 
Opportunistic infections and aids
Opportunistic infections and aidsOpportunistic infections and aids
Opportunistic infections and aids
acatanzaro
 
Lecture 10. diphtheria
Lecture 10. diphtheriaLecture 10. diphtheria
Lecture 10. diphtheria
Vasyl Sorokhan
 
Antibiotic associated diarrhea
Antibiotic associated diarrheaAntibiotic associated diarrhea
Antibiotic associated diarrhea
Samir Haffar
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
Kapil Dhital
 

What's hot (20)

Huntington's Disease
Huntington's DiseaseHuntington's Disease
Huntington's Disease
 
Genetic disorders
Genetic disordersGenetic disorders
Genetic disorders
 
Introduction to genetic disorders, classification 26 10-2016
Introduction to genetic disorders, classification 26 10-2016Introduction to genetic disorders, classification 26 10-2016
Introduction to genetic disorders, classification 26 10-2016
 
Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
 
Huntingtons disease
Huntingtons disease Huntingtons disease
Huntingtons disease
 
Opportunistic infections and aids
Opportunistic infections and aidsOpportunistic infections and aids
Opportunistic infections and aids
 
Single gene disorders
Single gene disordersSingle gene disorders
Single gene disorders
 
Alzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiologyAlzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiology
 
Lecture 10. diphtheria
Lecture 10. diphtheriaLecture 10. diphtheria
Lecture 10. diphtheria
 
Huntington disease
Huntington disease Huntington disease
Huntington disease
 
Genetic Disorders.ppt
Genetic Disorders.pptGenetic Disorders.ppt
Genetic Disorders.ppt
 
Genetic inheritance and chromosomal disorders
Genetic inheritance and chromosomal disordersGenetic inheritance and chromosomal disorders
Genetic inheritance and chromosomal disorders
 
Huntington
HuntingtonHuntington
Huntington
 
Huntington's disease & its Treatment
Huntington's disease & its TreatmentHuntington's disease & its Treatment
Huntington's disease & its Treatment
 
Antibiotic associated diarrhea
Antibiotic associated diarrheaAntibiotic associated diarrhea
Antibiotic associated diarrhea
 
Bacterial Diarrhea
Bacterial DiarrheaBacterial Diarrhea
Bacterial Diarrhea
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Review on microbiology and pathophysiology of tuberculosis
Review on microbiology and pathophysiology of tuberculosisReview on microbiology and pathophysiology of tuberculosis
Review on microbiology and pathophysiology of tuberculosis
 
Genetic diseases and gene therapy
Genetic diseases and gene therapyGenetic diseases and gene therapy
Genetic diseases and gene therapy
 
Gastrointestinal infections - bacteriology
Gastrointestinal infections - bacteriologyGastrointestinal infections - bacteriology
Gastrointestinal infections - bacteriology
 

Similar to Population genetics - How HIV-1 affect the body. CCR5 delta32

Acquired immunodeficiency syndrome
Acquired immunodeficiency syndromeAcquired immunodeficiency syndrome
Acquired immunodeficiency syndrome
abhishek144
 
Hivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPHHivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPH
Anjum Hashmi MPH
 

Similar to Population genetics - How HIV-1 affect the body. CCR5 delta32 (20)

AIDS
AIDSAIDS
AIDS
 
HIV VS AIDS. Can we prevent HIV transformation into AIDS?
HIV VS AIDS. Can we prevent HIV transformation into AIDS?HIV VS AIDS. Can we prevent HIV transformation into AIDS?
HIV VS AIDS. Can we prevent HIV transformation into AIDS?
 
Dengue
DengueDengue
Dengue
 
CD4 Cells Essay
CD4 Cells EssayCD4 Cells Essay
CD4 Cells Essay
 
Hiv infection
Hiv infectionHiv infection
Hiv infection
 
Dengue
DengueDengue
Dengue
 
Aids 1
Aids 1Aids 1
Aids 1
 
Dengue Fever
Dengue FeverDengue Fever
Dengue Fever
 
HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)
 
Acquired immunodeficiency syndrome
Acquired immunodeficiency syndromeAcquired immunodeficiency syndrome
Acquired immunodeficiency syndrome
 
AIDS PRESENTATION
AIDS PRESENTATIONAIDS PRESENTATION
AIDS PRESENTATION
 
AIDS
AIDSAIDS
AIDS
 
Adenosine Deaminase Deficiency
Adenosine Deaminase  DeficiencyAdenosine Deaminase  Deficiency
Adenosine Deaminase Deficiency
 
AIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .ppt
 
AIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .pptAIDS and its effect on Periodontium A look into the role .ppt
AIDS and its effect on Periodontium A look into the role .ppt
 
Human Immunodeficiency virus , (AIDS)
Human Immunodeficiency virus , (AIDS)Human Immunodeficiency virus , (AIDS)
Human Immunodeficiency virus , (AIDS)
 
Hivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPHHivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPH
 
Hiv Aids Best
Hiv Aids BestHiv Aids Best
Hiv Aids Best
 
HIV in the HAART Era Oral health seminar 2016.ppt
HIV in the HAART Era Oral health seminar 2016.pptHIV in the HAART Era Oral health seminar 2016.ppt
HIV in the HAART Era Oral health seminar 2016.ppt
 
Know aids for no AIDS !
Know aids for no AIDS !Know aids for no AIDS !
Know aids for no AIDS !
 

More from rabbibaidoo

More from rabbibaidoo (13)

Ganoderma lucidum
Ganoderma lucidumGanoderma lucidum
Ganoderma lucidum
 
M. Meselson and F. Stahl experiment
M. Meselson and F. Stahl experimentM. Meselson and F. Stahl experiment
M. Meselson and F. Stahl experiment
 
Desert biome
Desert biomeDesert biome
Desert biome
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Transplant immunology edd[1]
Transplant immunology edd[1]Transplant immunology edd[1]
Transplant immunology edd[1]
 
The complement system
The complement systemThe complement system
The complement system
 
Immuno haematology
Immuno haematologyImmuno haematology
Immuno haematology
 
Immunodeficiency group 3
Immunodeficiency group 3Immunodeficiency group 3
Immunodeficiency group 3
 
Hypersensitivity i
Hypersensitivity iHypersensitivity i
Hypersensitivity i
 
Hypersensitivity 3
Hypersensitivity 3Hypersensitivity 3
Hypersensitivity 3
 
Hypersesitivity ii
Hypersesitivity iiHypersesitivity ii
Hypersesitivity ii
 
Nucleotide biosynthesis-ppt-by-easybiologyclass
Nucleotide biosynthesis-ppt-by-easybiologyclassNucleotide biosynthesis-ppt-by-easybiologyclass
Nucleotide biosynthesis-ppt-by-easybiologyclass
 
Introduction to-genetics-ppt-by-easybiologyclass
Introduction to-genetics-ppt-by-easybiologyclassIntroduction to-genetics-ppt-by-easybiologyclass
Introduction to-genetics-ppt-by-easybiologyclass
 

Recently uploaded

Recently uploaded (20)

Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 

Population genetics - How HIV-1 affect the body. CCR5 delta32

  • 1. POPULATION GENETICS AND ECOLOGY PRESENTATION GROUP FOUR Members Index number • COFFIE BAIDOO RABBI UE20015317 • BUABENG ISAAC KOJO UE20015117 • DARKWAH JEPHTER UE20015717 • BALASU DELIGHT UE20014417 • BOATENG DAVID UE20014817 • BABAE THEOPHILUS UE20014217 • BRUCE BELINDAASIEDUA UE20015017 • DADEBOE VANESSA OHUI UE20014217
  • 2. HOW DOES HIV-1 AFFECT THE BODY? The human immunodeficiency virus is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome. HIV attacks a specific type of immune system cell in the body. It is known as the CD4 helper cell or T cell. The CD4 cell(cluster of differentiation 4) is a glycoprotein found on the surface of immune cells such as T helper cells, monocytes, macrophages and dendritic cells.
  • 3. When HIV destroy this cells, it becomes harder for the body to fight other infections. When HIV is left untreated even a minor infection such as cold can be much more severe because the body has difficulty responding to new infections. HIV does not only attack CD4 cells, it also uses the cells to make more of the virus. HIV destroy CD4 cells by using their replication machine to create new copies of the virus and this causes the CD4 cells to swell and burst. When the virus has destroyed a certain number of CD4 cells, the CD4 count drop below 200(the normal CD4 count ranges from approximately 500 to 1,600 cells/mm3 in healthy adults) then a person will progress to have AIDS.
  • 4. CERTAIN INDIVIDUALS CARRY A MUTATION PROTECTING THEM AGAINST HIV, DISCUSS. Some years ago, 1% descended from Northern Europeans, particularly Swedes, were immune to HIV infection. These lucky people are homozygous carriers of a mutated gene meaning that they inherited a copy from both of their parents. Just one copy of the gene does not prevent against the infection. Hence the mutation has not been found in Africans, East Asians, or Amerindians (NATIVE AMERICANS).
  • 5. A genetic mutation known as CCR5Δ32 is responsible for HIV resistance that exist. CCR5Δ32 hampers HIV ability to infilterate immune cells. Note; CCR5 stands for C-C Chemokine receptor type 5. The mutations causes the CCR5 co-receptor on the outside of the cells to develop smaller than usual and no longer sit outside of the cell. The CCR5 co-receptor is like the door that allows HIV entrance into the cell. The CCR5Δ32 mutation in a sense locks the door which prevents HIV from entering into the cell.
  • 6. CCR5Δ32 is exciting. It present possibilities for new ways to protect against HIV. There are some genetic test available to see if one has the mutation. But it is not yet widespread. The mutation is not completely full proof.
  • 7. Cases of homozygous carrier that have become infected with HIV have been reported. These few exceptions have dissuaded health officials from fully supporting genetic test over ethical concerns. It would not be wise for those with the mutation to assume that they can lead a dangerous lifestyle and remain healthy. Understanding why and how certain people are resistant to HIV with the help of CCR5Δ32 will hopefully lead to a new and highly successful treatments in our lifetime.
  • 8. Consider a sample population of 100 French individuals in Britain. Among this group 79 individuals had genotype +/+, 20 had +/Δ32 and 1 had a genotype of Δ32/Δ32, what are the possible allelic frequencies? • +/+ normal allele of the gene • Δ32/Δ32 mutant • +/Δ32 heterozygote
  • 9. SOLUTION Given that; Total population = 100 Individuals with normal allele of the gene (+/+) = 79 Individuals that carries the mutant gene (Δ32/Δ32) = 1 Heterozygous individuals of the gene (+/Δ32) = 20 To solve for the allelic frequency of +/+ = (+/+) x 2 + (+/Δ32) / (total population x 2) = (79 x 2) + 20 / (100 x 2) = 158 + 20 / 200 = 178 / 200 = 0.89
  • 10. To solve for the allelic frequency of Δ32/Δ32 = (Δ32/Δ32) x 2 + (+/Δ32) / 200 = (1 x 2) + 20 / 200 = 22 / 200 = 0.11 From Hardy-Weinberg equation; The sum of all tree genotypes is p2 + 2pq +q2 = 1 LET; • The probability of forming an +/+ zygote = p2 • The probability of forming an Δ32/Δ32 zygote = q2 • The probability of forming an +/Δ32 zygote = (p x q) + (q x p) • = pq + qp • = 2pq
  • 11. Substitute the values of p and q into the equation, = p2 + 2pq + q2 = (0.89)2 + 2(0.89 x0.11) + (0.11)2 = 0.7921 + 0.1958 + 0.0121 = 1. (note; the probability of 1 means certainty, and every individual must be one of the three genotypes) References; Dotinga , R. “Genetic HIV Resistance Deciphered” Wired. January 7, 2005 Evolution. Double Immunity (2001). Novembre, J., Galvani, A., and Slatkin, M. The Geographic Spread of the CCR5 Δ32 HIV Resistance Allele. PLOS Biology (2004) Biology, BURTON S. GUTTMAN